BRICS leaders call for stronger cooperation in disease surveillance, medical product regulation
BRICS leaders have committed to enhancing global health security by establishing an integrated early warning system for infectious diseases and strengthening medical product regulation. The New Delhi Declaration emphasizes the need for improved surveillance, local manufacturing of medical supplies, and the creation of a common GxP framework to standardize regulatory practices across member nations.
Why it matters
This initiative signals a strategic shift toward regional health autonomy and collective crisis response, potentially reducing reliance on Western-led health frameworks during future pandemics.
BRICS leaders on Saturday (September 12, 2026) called for stronger cooperation in disease surveillance and medical product regulation, welcoming the establishment of a dedicated sub-working group to advance an integrated early warning system for the prevention and response to mass infectious diseases.
In their New Delhi Declaration, the leaders stressed the importance of strengthening health infrastructure and local production of medical products to enhance preparedness for future health emergencies and ensure timely, affordable and equitable access to healthcare services, vaccines, therapeutics and diagnostics.
They also called for strengthened collaboration among BRICS medical products regulatory authorities and welcomed efforts to develop a common GxP white paper consolidating regulatory best practices and technical approaches.
The leaders recognised that infectious disease outbreaks, zoonotic threats, antimicrobial resistance and other public health emergencies transcend national borders and require stronger international cooperation, timely information sharing and coordinated action.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in